re: pharmaceuticals. I don't know, but I'd bet it's a pretty good idea that Dale is suggesting, that a package might be the best choice.
For individual companies, I've found that as Bob mentioned, buying on dips works (sometimes).
If somebody wants to buy now, then the issue for me is: does one buy the best performing company now(in terms of stock performance) or the worst performing? Here's a two year historical comparison of some that I follow (BAX and ABT wouldn't be considered pharmaceuticals by many - but I put 'em in that category anyway. I don't follow SGP, mentioned to you by Bob Rudd)
finance.yahoo.com
Perhaps the best performing (stock-price wise) companies in general (i.e. including all pharma., not just the ones on my chart) are the ones analysts expect to have the best growth over the next few years and where people expect the good stock price performance to continue. So one might want to buy those companies. For myself, I'd rather take companies that haven't moved up so much, where analysts expect lower sales or earnings or competitive or legal problems. And I'd go for the unexpected improvement. So I'd pick BMY (among the ones I follow). (aside: and I've been wrong many, many times)
Debby, from your profile, you're a nurse. Your opinion on a pharma. stock or medical products stock might be as good or better than anybody else's here! What's your fav. in these areas if I might politely inquire?
Paul Senior |
